Interactive Group Drumming (IGD) in Hospital Experience of Patients Undergoing Hematopoietic Stem Cell Transplant - A Pilot Study
Does Interactive Group Drumming (IGD) Improve the Hospital Experience of Patients Undergoing Hematopoietic Stem Cell Transplant? - A Pilot Study
2 other identifiers
interventional
35
1 country
1
Brief Summary
The purpose of this research is to determine if it is possible to perform group drumming as an intervention during HCT, to begin to understand how interactive group drumming during HCT treatment affects patients' well-being (good and bad) during the treatment course and in the first four weeks after completion of the drumming sessions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2017
CompletedStudy Start
First participant enrolled
November 15, 2017
CompletedFirst Posted
Study publicly available on registry
November 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 25, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 4, 2019
CompletedMay 14, 2020
December 1, 2019
1.9 years
October 20, 2017
May 11, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Rate of participation
Defined as the number of subjects willing to participate in the interactive group drumming (IGD) divided by the number approached and asked to participate. These rates will be reported, along with the corresponding 95% confidence interval.
Up to 1 week after hematopoietic cell transplant (HCT)
Rate of completion
Defined as the ratio of (the number of individuals who successfully complete the study \[4 sessions of IGD (about 20 minutes \[min.\] each)\], with two pre-and post- surveys \[8 minutes total, and two questionnaires (10 minutes total) about 160 minutes total time\]) relative to the number of individuals who consent to the study (the number from the numerator of the first ratio \[participation\]). These rates will be reported, along with the corresponding 95% confidence interval.
Up to 1 week after HCT
Secondary Outcomes (6)
Gather patient-reported data to suggest how participants respond to interactive group drumming (IGD)
Baseline up to 4 weeks after completion of IGD
Determine optimum length of session
Up to 4 weeks after completion of IGD
Gather patient-reported information to study whether the effect of interactive group drumming (IGD) on targeted variables is more pronounced in successive sessions
Baseline up to 4 weeks after completion of IGD
Effect of support care provider (SCP) presence for each participant and among participants
Up to 4 weeks after completion of IGD
Change in physiological response to interactive group drumming (IGD)
Baseline up to 1 week after HCT
- +1 more secondary outcomes
Study Arms (1)
interactive group drumming sessions
EXPERIMENTALParticipants will be involved in four interactive group drumming sessions (10-30 minutes each) and complete surveys and questionnaires about music and quality of life.
Interventions
interactive group drumming sessions
Eligibility Criteria
You may qualify if:
- People who are at least 18 years old and are scheduled for HCT
- Individuals must be able to understand and willing to sign a written informed consent form
You may not qualify if:
- People who are too ill to participate, i.e., while they are in contact isolation or have low platelets (less than 20,000/mcl) will not participate until their condition has improved.
- Patients receiving outpatient HCT except patients with multiple myeloma. Patients with multiple myeloma may participate in the study even though they tend to spend nights away from the hospital.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
Study Officials
- STUDY CHAIR
Richard McQuellon, PhD
Wake Forest University Health Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 20, 2017
First Posted
November 17, 2017
Study Start
November 15, 2017
Primary Completion
September 25, 2019
Study Completion
December 4, 2019
Last Updated
May 14, 2020
Record last verified: 2019-12